AbbVie expands board to 13, appoints UC San Diego health chief

AbbVie Inc. (NYSE: ABBV) expanded its Board of Directors from 12 to 13 members on October 14, 2026, appointing Dr. John M. Carethers as a Class II director.

Dr. Carethers currently serves as Vice Chancellor for Health Sciences at the University of California San Diego and previously served as a director of Avantor, Inc. He has been appointed to AbbVie's Public Policy and Sustainability Committee.

The board determined that Dr. Carethers qualifies as an independent director under the New York Stock Exchange Listed Company Manual standards and AbbVie's own governance guidelines. His compensation as an independent director will follow the terms disclosed in AbbVie's Quarterly Report on Form 10-Q for the period ended March 31, 2025.

You May Also Be Interested In

• Bank of America adds two former CEOs to its board
• Abbvie (ABBV) PT Raised to $325 at Barclays
• Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges